Braskem S.A.
NYSE:BAKChemicals
-$0.40 today
- Market cap
- $343.37M
- Beta
- 0.67
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$11.45
Volume 3.32M
Average 2.97M
BAK Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Braskem S.A.NYSE: BAK
Operating Income · Q1 FY2026 · quarter ended Mar 2026
Operating income turns negative
Q1 FY2026 operating income was -R$217M, compared with R$99M a year earlier. Trailing-twelve-month operating income was -R$1.99B.
Context
- Operating income amounted to 5.7% of revenue in FY2025, up 4.4 pp from a year earlier.
- Operating income increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether operating income reaches the consensus estimate from 1 analysts of R$6.96B (+276.2%) for the fiscal year ending Dec 2026, a step up from the -490.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -R$217M-292.0% QoQ
- Last fiscal yearDec 2025
- -R$3.95B-490.3% YoY
- LTMMar 2026
- -R$1.99B-401.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -319.2% | +679.2% | +998.4 pp |
| 1 year | -490.3% | +276.2% | +766.5 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
BRL · from the income statement
- Latest · FY2025
- (3.95B) BRL
- Year-over-year change
- -490.3%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.95B) | -490.3% |
| FY2024 | 2024-12-31 | 1.01B | +157.8% |
| FY2023 | 2023-12-31 | (1.75B) | -128.6% |
| FY2022 | 2022-12-31 | 6.11B | -77.5% |
| FY2021 | 2021-12-31 | 27.18B | — |
Operating Income vs competitors
How BAK compares with its peers on the latest reported figures
- Peers report in different currencies, so operating income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -401.7% is the lowest of 11, against a peer median of -0.2%.
- Operating income amounts to 3.0% of revenue for BAK, versus a peer median of 11.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $359.54M USD | +5.1% | -2.8% | 29.1% | |
| LTM Mar 2026 | $151.88M USD | +44.8% | -26.0% | 23.6% | |
| LTM Mar 2026 | $96.44M USD | +14.4% | -9.1% | 11.8% | |
| LTM Apr 2026 | $72.04M USD | +11.9% | +33.3% | 11.0% | |
| LTM Mar 2026 | $56.91M USD | -27.6% | -30.6% | 2.4% | |
| LTM Mar 2026 | $6.91M USD | -5.5% | +5.8% | 0.5% | |
| LTM Mar 2026 | $3.54M USD | +109.8% | — | 1.5% | |
| LTM Mar 2026 | -CA$22.45M CAD | -26.6% | — | — | |
CNLCollective Mining Ltd. | LTM Mar 2026 | -$48.32M USD | -89.1% | — | — |
| LTM Mar 2026 | -$74.13M USD | -160.2% | — | 275.3% | |
| LTM Mar 2026 | -R$1.99B BRL | -401.7% | — | 3.0% | |
| Peer median (excluding BAK) | — | -0.2% | -5.9% | 11.4% | |
Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 105.63B | 96.52B | 70.57B | 77.41B | 69.33B |
| Cost of Revenue | 73.57B | 85.16B | 67.55B | 71.41B | 67.8B |
| Gross Profit | 32.06B | 11.36B | 3.02B | 6B | 1.53B |
| Gross Margin | 30.3% | 11.8% | 4.3% | 7.7% | 2.2% |
| Research & Development | 297M | 374M | 383M | 463M | 450.96M |
| Selling, General & Admin | 4.58B | 4.87B | 4.39B | 4.63B | 4.68B |
| Operating Expenses | 4.88B | 5.25B | 4.77B | 4.99B | 5.48B |
| Depreciation & Amortization | 4.18B | 4.73B | 5.21B | 3.75B | 4.58B |
| EBITDA | 25.33B | 8.11B | 3.26B | 2.7B | 631.35M |
| EBITDA Margin | 24.0% | 8.4% | 4.6% | 3.5% | 0.9% |
| Operating Income | 27.18B | 6.11B | (1.75B) | 1.01B | (3.95B) |
| Operating Margin | 25.7% | 6.3% | -2.5% | 1.3% | -5.7% |
| Interest Income | 440M | 1.05B | 873M | 1.26B | 711.74M |
| Interest Expense | 3.19B | 3.33B | 4.78B | 5.44B | 5.82B |
| Other Income / Expenses | (9.22B) | (6.07B) | (4.44B) | (18.75B) | 1.16B |
| Income Before Tax | 17.96B | 47M | (6.19B) | (17.73B) | (2.79B) |
| Pre-Tax Margin | 17.0% | 0.0% | -8.8% | -22.9% | -4.0% |
| Income Tax Expense | 4B | 868M | (1.3B) | (5.68B) | 7.96B |
| Net Income | 13.99B | (336M) | (4.58B) | (11.32B) | (9.69B) |
| Net Margin | 13.2% | -0.3% | -6.5% | -14.6% | -14.0% |
| EPS (Basic) | 35.12 | (2.06) | (11.50) | (28.40) | (24.32) |
| EPS (Diluted) | 35.08 | (2.06) | (11.50) | (28.40) | (24.32) |
| Weighted Avg Shares | 398.11M | 398.24M | 398.35M | 398.6M | 398.6M |
| Weighted Avg Shares (Diluted) | 398.61M | 398.6M | 398.35M | 398.6M | 398.6M |
Braskem S.A.
NYSE:BAK
Intrinsic Alpha fair value
Locked
Current Price
$0.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.